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PRELIMINARY AND SHORT REPORT
A COMPARISON OF THE INHIBITORY EFFECT OF 9a FLUOR-HYDROCOR-
TISONE ACETATE AND HYDROCORTISONE ACETATE OINTMENTS ON
ECZEMATOUS REACTIONS PRODUCED BY ELECTROPHORESIS*
H. HAXTHAUSEN, M.D.
Hvcjrocortisone acetate i a compound which exerts a definite suppressing action on
eczematous-allergic reactions. In experiments with eleetrophoretic-induced eezematous
reactions (Haxthausen) (4) the suppressing action was found constantly after intracuta-
neous injection of a suspension of hydrocortisone, whereas epidutaneous application (patch
tests with 2% hydrocortisone in various ointment bases) showed a distinct sparing of the
eczematous reaction in only a few cases. Further experiments with hydrocortisone alcohol in
ointment or in solution (5 mg/ml. in 50% ethanol) have shown omewhat better results, the
former distinct sparing in 4 of 8 experiments, the latter in 5 of 9.
FIG. 1. Eczematous reaction after electrophoresis of quilline chloride. Patch-test with
2% 9a fluorhydroeortione acetate oinl inent (top) : Di&tinet inhibition. 2% hytiro-
cortisone acetate ointment (below) No inhibit ion.
Recenllv a new derivative, 9 Fluorhydioeortione acelate has been introduced and
reported 10 have many times the metabolic and I herapeutic activil y of hydrocortisone
acetate after parenteral use (Goldfien, Beigelman, Laidlaw and Thorn (2)). This compound
has been tried experimentally by Goldman, Flalt and Baskett (3) and clinically as topical
appli cal ions in van mis dermnat ose by Will en, SuI zi erge r Zi mine mm an a mid Shapiro (5)
and a comparison wit Ii Imvdrocortisone acetate has proved I lie fluor—derival ive to he tIme
more effective.
* From the Department of Dermatology, liiniversitv of Copenhagen. (Chief: Professor
H. Haxthausen, M.D.).
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TABLE I
Inhibition of cezematous eleetrophorelic reactions. ++ strong to complete, + slight to moderate,
0 no inhibition
Case No. Provoking Substance 23.% I31ydrocortisone
Mercury 0 0
2 Quinine ++ 0
3 Cincainc + 0
4 Nickel + +
5 Mercury + 0
6 Chromate ++ +
7 Dinitrochlorobenzene ++ +
8 Mercury 0 0
9 Nickel + 0
10 Iodine 0 0
RESULT: 9a Fluor-hydrocortisone acetate: Strong: 3, moderate: 4, no inhibition:
3 cases. Hydrocortisone acetate: Strong 0, moderate: 3, no inhibition: 7 cases.
I therefore decided to examine the fluor derivative experimentally using the electro-
plioretic-induced eczematous reactions as test object in the same way as in previous cx-
perlinents. In a series of 8 cases of contact eczema, electrophoresis with the specific allergen
was performed on the back of the subjects using an electrode about 3 cm. in diameter.
Immediately thereafter two patch tests of 1 sq. cm. in size were applied to the treated area,
0110 with 22% of the fluor-compound, one with 22% hydrocortisone acetate in an indiffer-
ent ointment base. In 2 additional cases, hypersensitive to iodine mid dinitrochlorobenzene,
the provoking substance was simply applied to the skin in alcoholic solution and the patch-
tests performed after evaporation of the alcohol. The results were read after 24 and 48
hours and clearly indicate, as the Table shows, a superiority of the fluor-compound with
regard to the sparing influence on the eczeinatous reaction; hut the effect is not constant
and is rarely complete. The search for hydrocortisone derivatives with still better local
action should therefore he continued. The stronger effect of the fluor-compound is presum-
ably partly due to a better penetration, which is perhaps also responsible for the rather
serious systemic reactions reported by Fitzpatrick et al. (1) after percutaneous absorption
of the compound.
SUMMARY
A comparison of 9a fluorhydrocortisone acetate and hydrocortisone acetate in 212%
ointment, by topical application as patch tests on electrophoretically induced eczematous
reactions has shown that the fluor-compound is the most effective in suppressing the eczein-
atous reaction; but that the effect is not constant and is rarely complete.
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